ACE2: from vasopeptidase to SARS virus receptor
Anthony J Turner, Julian A Hiscox, Nigel M Hooper, Anthony J Turner, Julian A Hiscox, Nigel M Hooper
Abstract
The zinc metallopeptidase angiotensin-converting enzyme 2 (ACE2) is the only known human homologue of the key regulator of blood pressure angiotensin-converting enzyme (ACE). Since its discovery in 2000, ACE2 has been implicated in heart function, hypertension and diabetes, with its effects being mediated, in part, through its ability to convert angiotensin II to angiotensin-(1-7). Unexpectedly, ACE2 also serves as the cellular entry point for the severe acute respiratory syndrome (SARS) virus and the enzyme is therefore a prime target for pharmacological intervention on several disease fronts.
Figures
References
- Turner A.J, Hooper N.M. The angiotensin-converting enzyme gene family: genomics and pharmacology. Trends Pharmacol. Sci. 2002;23:177–183.
- Acharya K.R. ACE revisited: a new target for structure-based drug design. Nat. Rev. Drug Discov. 2003;2:891–902.
- Tipnis S.R. A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 2000;275:33238–33243.
- Donoghue M. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 2000;87:E1–E9.
- Zisman L.S. Increased angiotensin-(1-7)-forming activity in failing human heart ventricles. Evidence for up-regulation of the angiotensin-converting enzyme homologue ACE2. Circulation. 2003;108:1707–1712.
- Averill D.B. Cardiac angiotensin-(1-7) in ischemic cardiomyopathy. Circulation. 2003;108:2141–2146.
- Ferrario C.M. Counterregulatory actions of angiotensin-(1-7) Hypertension. 1997;30:535–541.
- Crackower M.A. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417:822–828.
- Donoghue M. Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins. J. Mol. Cell. Cardiol. 2003;35:1043–1053.
- Chen A.A. Two single nucleotide polymorphisms in the ACE2 locus are associated with cardiovascular disease. Gen. Epidemiol. 2002;23:272.
- Tikellis C. Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension. 2003;41:392–397.
- Dales N.A. Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors. J. Am. Chem. Soc. 2002;124:11852–11853.
- Huang L. Novel peptide inhibitors of angiotensin-converting enzyme 2. J. Biol. Chem. 2003;278:15532–15540.
- Guy J.L. Angiotensin-converting enzyme-2 (ACE2): Comparative modeling of the active site, specificity requirements, and chloride dependence. Biochemistry. 2003;42:13185–13192.
- Natesh R. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature. 2003;421:551–554.
- Rota P.A. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 2003;300:1394–1399.
- Marra M.A. The genome sequence of the SARS-associated coronavirus. Science. 2003;300:1399–1404.
- Li W. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450–454.
- Xiao X. The SARS-CoV S glycoprotein: expression and functional characterization. Biochem. Biophys. Res. Commun. 2003;312:1159–1164.
- Wong S.K. A 193-amino-acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J. Biol. Chem. 2004;279:3197–3201.
- Prabakaran P. A model of the ACE2 structure and function as a SARS-CoV receptor. Biochem. Biophys. Res. Commun. 2004;314:235–241.
- Towler, P. et al. ACE2 structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J. Biol. Chem. (in press).
- Yeager C.L. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature. 1992;357:420–422.
- Brosnihan K.B. Enhanced renal immunocytochemical expression of ANG-(1-7) and ACE2 during pregnancy. Hypertension. 2003;42:749–753.
- Vickers C. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J. Biol. Chem. 2002;277:14838–14843.
- Cavanagh D. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathol. 2003;32:567–582.
- Hiscox J.A. The interaction of animal cytoplasmic RNA viruses with the nucleus to facilitate replication. Virus Res. 2003;95:13–22.
Source: PubMed